Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001242896.3(DEPDC5):c.2020C>A(p.Arg674Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R674C) has been classified as Likely benign.
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);.;Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);.;Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);Gain of phosphorylation at R674 (P = 0.0833);.;